GlassScriptPhysician profile
Mario Jitano Cole
NPI 1356328991
$7,661.57
in general payments reported to CMS, 2019-2025
37 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,183 · 2020: $472 · 2021: $448 · 2022: $1,050 · 2023: $1,143 · 2024: $2,095 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,410 · Travel and Lodging: $980 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,409.81 |
| Travel and Lodging | $980.10 |
| Education | $117.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,752.81 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Noah Medical Corporation | $1,188.85 | 2024 | Galaxy |
| Astrazeneca Pharmaceuticals LP | $496.98 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Genzyme Corporation | $469.85 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.48 | 2019-2025 | Ofev |
| Grifols USA, LLC | $262.86 | 2019-2024 | Prolastin-C Liquid |
| Sk Life Science, INC. | $177.28 | 2025 | |
| Sanofi-Aventis U.S. LLC | $176.98 | 2022-2025 | |
| Abbvie INC. | $163.02 | 2021-2023 | Qulipta |
| Novartis Pharmaceuticals Corporation | $146.41 | 2022-2024 | |
| Intuitive Surgical, INC. | $122.78 | 2023-2024 | |
| Philips North America LLC | $110.84 | 2019-2025 | (8874) Incourage, Vest Therapy Und |
| Amgen INC. | $94.15 | 2022-2024 | Tezspire |
| Olympus America INC. | $92.90 | 2021-2023 | Spiration Valve System |
| Teva Pharmaceuticals USA, INC. | $85.81 | 2019-2023 | Austedo, Airduo Digihaler |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $70.04 | 2019-2023 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $69.28 | 2019 | |
| Veran Medical Technologies, INC. | $65.83 | 2019 | |
| Pulmonx Corporation | $56.64 | 2024-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Genentech USA, INC. | $56.07 | 2023-2025 | Xolair |
| Mylan Specialty L.P. | $54.74 | 2019-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $54.00 | 2019-2025 | |
| Insmed, INC. | $53.91 | 2025 | Brinsupri, Arikayce |
| Medtronic Vascular, INC. | $53.80 | 2019 | |
| Viatris Specialty LLC | $53.62 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $51.16 | 2023-2024 | Xarelto |
| Sunovion Pharmaceuticals INC. | $41.79 | 2019 | |
| Verona Pharma, INC. | $38.65 | 2025 | Ohtuvayre |
| Ucb, INC. | $33.73 | 2025 | Rystiggo |
| Medtronic, INC. | $26.52 | 2025 | Illumisite |
| Baxter Healthcare | $26.05 | 2023 | Hillrom - Life 2000 Ventilation System |
| Avanir Pharmaceuticals, INC. | $24.97 | 2022 | |
| Boston Scientific Corporation | $23.64 | 2024 | Wavewriter Alpha Prime 16 |
| Harmony Biosciences LLC | $21.62 | 2022 | |
| Gilead Sciences, INC. | $20.56 | 2019 | |
| Allergan, INC. | $16.87 | 2020 | |
| Lilly USA, LLC | $14.08 | 2025 | Kisunla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.